INTRODUCTION
During the evolutionary processes, life has made use of iron in a variety of biochemical processes. For instance, iron is an essential cofactor for non-heme enzymes, such as ribonucleotide reductase, which is essential for DNA synthesis and is also a vital component of the heme in the oxygen-binding protein, hemoglobin (1) (2) (3) . Iron needs to be tightly regulated, as excess iron is toxic and causes the generation of free radicals (4), whereas iron insufficiency induces hypoferric anemia in mammals (5) coupled to hypoxia in tissues (6, 7) .
the oldest reported experiment of iron-induced carcinogenesis is that of mice exposed to iron oxide dust, which caused pulmonary tumors (11) . In addition, various studies have also shown higher levels of expression of the transferrin receptor 1 (TfR), which is an essential protein involved in iron uptake and the regulation of cell growth, in cancer cells than in their normal counterparts (12) . TfR could be attributed to the increased need for iron as a cofactor of ribonucleotide reductase involved in the DNA synthesis of rapidly dividing cells. These reports suggest that iron homeostasis is important in cancer initiation and progression. However, the regulatory mechanisms of iron homeostasis in cancer cells are not yet fully understood. microRNAs (miRNAs) have emerged as a new class of noncoding genes involved in regulating a wide variety of biological processes (13, 14) , and their mis-expression has been shown to contribute to tumorigenesis (15) . Therefore, miRNAs act as tuners of gene expression and maintain homeostasis. For instance, miR-144/451 knockout mice display a cell autonomous impairment of late erythroblast maturation, resulting in erythroid hyperplasia, splenomegaly, and mild anemia (16) .
In a previous report, we demonstrated that miR-210 is highly expressed in human and murine erythroid cells and in the spleen of mice with hemolytic anemia (17) . Erythrocytes require iron to perform their duty as oxygen carriers. Recent reports have shown that the expression of miR-210 is induced by hypoxic conditions (18) . Therefore, miR-210 might play an important role in the connection of iron and oxygen. It was already reported that the expression of miR-210 was tightly associated with poor prognosis of breast cancer (18) ; however, contradictory data exist concerning the regulation and roles of miR-210 during cancer progression. In this study, we clarified that miR-210 regulates iron homeostasis in cancer cells. The expression of miR-210 was induced not only in hypoxic conditions but also in iron deficiency. In addition, we found that the targets of miR-210 are two essential molecules for iron homeostasis, TfR and the iron-sulfur cluster scaffold protein (ISCU). Furthermore, we showed that the distribution of miR-210-expressing cells in inoculated tumor cells could be observed in the chronic hypoxic regions. These results indicated that iron deficiency-inducible miR-210 controls the expression of two iron regulatory proteins to optimize the survival and proliferation rate of cancer cells located in the chronic hypoxic regions.
EXPERIMENTAL PROCEDURES
Reagents---Rabbit polyclonal anti-ISCU (FL-142) (sc-28860) was purchased from Santa Cruz Biotechnology. Mouse monoclonal anti-TfR (13-6800) was from Invitrogen. Mouse monoclonal anti-actin, clone C4 (MAB1501), was from Millipore. Mouse monoclonal anti-HIF-1α (610959) was purchased from BD Pharmingen. Rabbit monoclonal anti-ferritin (EPR3004Y) was purchased from EPITOMICS. Rabbit polyclonal anti-ACO1/IRP1 was purchased from MBL. Rabbit polyclonal anti-Red Fluorescent Protein (RFP) (ab34771) was purchased from Abcam. Peroxidase-labeled anti-mouse and anti-rabbit antibodies were included in the Amersham Biosciences ECL PLUS Western blotting reagents pack (RPN2124) (GE HealthCare). Synthetic hsa-miR-210 (pre-miR-210) and antisense miR-210 oligonucleotide (anti-miR-210) were purchased from Ambion (Austin, TX). The duplexes of each small interfering RNA (siRNA) targeting human HIF-1α mRNA (s30925; target sequences of 5'-GGAGGUGUUUGACAAGCGAdTdT-3' and 5'-UCGCUUGUCAAACACCUCCtg-3'), an siRNA specific for human IRP1 (ACO1) mRNA (target sequences of 5'-GCUCGCUACUUAACUAACAtt-3' and 5'-UGUUAGUUAAGUAGCGAGCag-3') and negative control 1 (NC1) were purchased from Applied Biosystems. An siRNA specific for human TfR mRNA (target sequences of 5'-GAACCUGGAUAAUGAUGAAdTdT-3' and 5'-UUCAUCAUUAUCCAGGUUCdTdT-3') was purchased from Sigma-Genosys. Desferrioxamine (DFO) was purchased from Calbiochem (Darmstadt, Germany). Geneticin was purchased from Invitrogen.
Cell
Culture---MCF7 cells and MD-MB-231-luc-D3H2LN cells (Xenogen), a human breast cancer cell line, were cultured in RPMI 1640 containing 10% heat-inactivated fetal bovine serum (FBS) and an antibiotic-antimycotic (Invitrogen) at 37°C in 5% CO 2 .
Exposure to hypoxia---Cells were exposed for 24 h or 48 h either to standard non-hypoxic cell culture conditions (20% O 2 , 5% CO 2 , with N 2 balance at 37°C) or to hypoxia (1% O 2 , 5% CO 2 with N 2 balance at 37°C) in either a modular hypoxia chamber (Wakenyaku) or a tissue culture incubator.
RNA extraction---RNA was isolated using Trizol (Invitrogen) and processed according to the manufacturer's instructions.
Quantitative real-time RT-PCR (qRT-PCR)---
Hsa-miR-210 and endogenous control RNU6B TaqMan qRT-PCR kits and human-ISCU, human-TfR, and human-β-actin TaqMan Gene Expression Assays were purchased from Applied Biosystems (Foster City, CA). The reverse transcription and TaqMan quantitative PCR were performed according to the manufacturer's instructions. PCR was carried out in 96-well plates using the 7300 Real-Time PCR System (Applied Biosystems). All reactions were done in triplicate. The expression levels of pri-miR-210 and β-actin were measured by qRT-PCR using a SYBR Green PCR master mix (Invitrogen). Primer sequences are as follows (shown 5' to 3'):
pri-miR-210 F, GACTGGCCTTTGGAAGCTCC and R, ACAGCCTTTCTCAGGTGCAG; β-actin F, GGCACCACCATGTACCCTG and R, CACGGAGTACTTGCGCTCAG.
In silico microRNA target prediction---Bioinformatic prediction of target genes and miRNA binding sites was performed using three programs: TargetScan (version 5.0) (19) , Sanger MirBase (version 5) (20) , and MiRTarget2 (21). Immunoblot analysis---SDS-PAGE gels were calibrated with Precision Plus protein standards (161-0375) (Bio-Rad), and anti-HIF-1α (1:500), anti-ISCU (1:200), anti-TfR (1:500), and anti-actin (1:1,000) were used as primary antibodies. The dilution ratio of each antibody is indicated in parentheses. Two secondary antibodies (peroxidase-labeled anti-mouse and anti-rabbit antibodies) were each used at a dilution of 1:10,000. Bound antibodies were visualized by chemiluminescence using the ECL Plus Western blotting detection system (RPN2132) (GE HealthCare), and luminescent images were analyzed with a LuminoImager (LAS-3000; Fuji Film Inc.).
3'UTR assay plasmid constructs---
Flow cytometric analysis---MCF7 cells and MDA-MB-231-luc-D3H2LN cells were transfected with pre-miR-210 or pre-NC. After culturing for 48 h, transfected cells were serum-starved for 30 min and then incubated for 45 min in a serum-free medium containing 50 µg of transferrin/ml conjugated with Alexa Fluor 594 (Invitrogen). Transfected cells were suspended in their culture medium and subjected to a FACSAria II cell sorter (BD Biosciences). At least one million cells were pelleted by centrifugation at 180 x g for 5 minutes at 4°C, resuspended in a 20 µl of a monoclonal mouse anti-human CD71-FITC antibody (BD Biosciences, clone M-A712) and incubated for 30 min at 4°C. Three independent experiments were performed.
Transferrin uptake analysis---Transferrin uptake experiments were performed 48 h after transfection with pre-miR-210 or pre-NC. Transfected cells were serum-starved for 30 min and then incubated for 45 min in a serum-free medium containing 50 µg of transferrin/ml conjugated with Alexa Fluor 594 (Invitrogen). Cells were then washed and fixed in 4% paraformaldehyde for 15 min at room temperature. After washing with PBS, they were incubated with mouse anti-TfR antibody diluted 1:100 in Dako REAL Antibody Diluent (Dako, Carpinteria, CA, USA) for 1 h. They were then incubated with Alexa Fluor 488 goat anti-mouse IgG diluted 1:1000 in Dako REAL Antibody Diluent for 45 min. Finally, the cells were stained with the fluorescent DNA-binding dye Hoechst 33342 (Invitrogen) for 5 min.
Establishment of stable cell lines---Stable
knockdown of ISCU MCF7 cell lines was generated by selection with 4 µg/ml blasticidine (Invitrogen). MCF7 cells were transfected with 0.5 mg of an siISCU1/2 vector or a negative control vector at 90% confluency in 24-well dishes using a Lipofectamine LTX reagent in accordance with the manufacturer's instructions. After 24 h, the cells were replated in a 10-cm dish followed by 3-week selection with 4 µg/ml blasticidine.
Immunohistochemical staining---Between all consecutive steps of the staining procedure, the sections were rinsed three times for 5 min in PBS. The sections were first fixed in 10% formalin for 4 h. After re-hydration of the tissue sections in PBS for 1 h, they were incubated with mouse anti-HIF-1α diluted 1:500 and rabbit anti-RFP diluted 1:100 in Dako REAL Antibody Diluent (Dako, Carpinteria, CA, USA) for 1 h. Sections were then incubated with Alexa Fluor 488 goat anti-mouse IgG and Alexa Fluor 594 goat anti-rabbit IgG (Molecular Probes, Leiden, The Netherlands) diluted 1:1000 in Dako REAL Antibody Diluent for 45 min. Finally, sections were mounted on ProLong Gold antifade reagent with DAPI (Invitrogen). Statistical analysis---Data presented as bar graphs are the means ±s.e.m. of at least three independent experiments. Statistical analysis was performed using the Student's t-test.
In vivo miR-210 monitoring assay---

RESULTS
Iron deficiency induces the expression of miR-210 through the HIF-1α and miR-210 directly suppresses ISCU To try to determine the possible contribution of miR-210 in the regulation of iron homeostasis, we first measured the expression of miR-210 in breast cancer cells, MCF7 and MDA-MB-231 (MM231) cells and human breast epithelial cells, MCF10A, after treatment with an iron chelator, desferrioxamine (DFO). The expression level of miR-210 was increased 3-to 5-fold above basal levels by the 48 h of DFO treatment compared with untreated cells (Fig. 1A) . In addition, excess amounts of iron by addition of 500 mM ferric ammonium citrate (FAC) had no effect on the induction or suppression of the expression of miR-210. To further analyze whether the biogenesis of miR-210 during iron depletion is regulated by a transcriptional mechanism or processing machinery of miRNA biogenesis, we quantified the expression of primary miR-210 (pri-miR-210) in MCF7 cells. The expression of pri-miR-210 levels was induced 1.5-to 3.5-fold above basal levels by the DFO treatment compared with untreated cells (Fig. 1B) . This result indicated that the induction of miR-210 is due to transcriptional regulation. As shown previously, the transcription of miR-210 was regulated by iron deficient induced HIF-1α through the binding of Hypoxia-responsible elements which are located upstream of miR-210 gene (22) (supplemental Figs. S1A-D) . Indeed, suppression of HIF-1α by siRNA (supplemental Fig. S1E ) leads a significant reduction of miR-210 expression after treatment with DFO (Fig. 1C) .
Recent reports showed that miRNAs play a role in feedback and feed-forward transcriptional regulation (23, 24) . Previously, we reported that miR-210 is involved in the production of erythrocytes, which consume 70% of body iron in humans and are the major carriers of oxygen (17, 25) . Based on those reports and our finding that the expression of miR-210 was regulated by the iron concentration through the activation of HIF-1α in this report (Figs. 1A-C and supplemental Fig. S1 ), we hypothesized that miR-210 regulates genes that are associated with a potent iron homeostasis and a hypoxic cellular response. According to these criteria, ISCU was predicted as an miR-210 target by miRNA target prediction algorithm programs (supplemental Fig. S2A ). ISCU is an essential factor of the mitochondria electron transport chain, and loss of function of ISCU can disrupt iron homeostasis (26) . Although ISCU was known to be regulated by miR-210 in hypoxic condition (27, 28) , the precise mechanism of miR-210 on iron homeostasis in cancer cells has not been clarified yet. As shown in Fig. 1D , miR-210 recognized the 3'UTR of ISCU. On the contrary, miR-210 seed sequence in the 3'UTR of ISCU was mutated or deleted, miR-210 could not bind to the 3'UTR of ISCU (Fig. 1D) (Figs. 1E, F) . These results are consistent with previous findings that ISCU was direct target of miR-210. To understand the contribution of miR-210 and ISCU on iron homeostasis in breast cancer cells, we checked the expression of ISCU under the condition of iron depletion in breast cancer cells. As shown in Fig. 1G , the expression of ISCU was downregulated after the treatment with DFO, suggesting that the expression of ISCU was controlled by iron-deficient induced miR-210 in breast cancer cells. These results prompted us the idea that iron-ISCU pathway might regulate the iron homeostasis in breast cancer cells.
miR-210 suppresses the major iron uptake protein TfR
In mammalian cells, knockdown of ISCU markedly reduces mitochondrial aconitase activity and then promotes the activity of iron regulatory protein1 (IRP1). Activation of IRP1 accelerates the binding to multiple iron-responsive elements (IREs) in the 3'UTR of the mRNA, such as TfR involved in iron acquisition, then leading to increased mRNA stability (26) . When IRP1 binds to the 3'UTR of TfR mRNA, which is an iron-uptake protein, the transcript is protected from degradation. Therefore, we hypothesized that overexpression of miR-210 stabilizes mRNA of TfR via the activation of IRP1. To prove this hypothesis, we measured the expression of mRNA and the protein level of TfR after transfection of the miR-210 mimic (pre-miR-210) in MCF7 and MM231 cells. Surprisingly, the expression of TfR was downregulated after the transfection of pre-miR-210 (Figs. 2A, B and supplemental Fig.  S4A ). This is an unexpected result because the expression of TfR was increased in ISCU stably knockdown cells (Fig. 2C and supplemental Fig.  S2E ). Those results led us to consider that miR-210 directly suppressed the expression of TfR by binding to the 3'UTR of TfR. To check whether or not TfR is a direct target gene of miR-210, we once again used in silico algorithms and found that there was an miR-210 binding site at 3'UTR of TfR (Fig. 2D) . To prove that miR-210 directly recognizes the identical predicted target site in the 3'UTR of TfR, MCF7 cells were transfected with psi-TfR, which was fused to 3'UTR of TfR and the luciferase open reading frame, or a control vector. In addition, we also prepared psi-TfR_mut, which has a mutated sequence of a putative miR-210 binding site or psi-TfR_del, which was deleted a putative miR-210 binding site.
Co-transfection of pre-miR-210 downregulated Renilla luciferase activity significantly more than in pre-NC in the presence of psi-TfR. In contrast, Renilla luciferase activity was not altered in the presence of psi-TfR_del or psi-TfR_mut (Fig.  2E) . We confirmed that miR-210 targets the 3'UTR of TfR mRNA, showing that miR-210 directly suppresses not only ISCU but also TfR. TfR plays a major role in cellular iron uptake through binding to and internalizing a carrier protein transferrin (Tf). Therefore, to examine whether reduction of TfR by transfected pre-miR-210 functionally inhibited the uptake of Tf or not, Alexa 594-labeled Tf was used to monitor the uptake of Tf by immunostaining and FACS analysis. As shown in Fig. 2F and Fig. 2G , uptake of Tf was lower in pre-miR-210 transfected cells than in control cells, indicating a direct correlation between TfR reduction and the decreased uptake of Tf in miR-210-overexpressing cells (Figs. 2F,G) . We also confirmed similar results using an MM231 cells (supplemental Figs. S4B, C) . Consequently, these observations indicated that overexpression of miR-210 decreases the concentration of intracellular iron by inhibiting the Tf-TfR-dependent iron uptake system.
miR-210 is a member of iron homeostatic networks
As shown in Fig. 2 , overexpression of miR-210 inhibited the uptake of Tf via the suppression of TfR. However, since overexpression of miR-210 by miR-210 mimics transduces an extremely high amount of miRNA in the cells (supplemental Fig. S3A ), it is necessary to examine the function of miR-210 in iron homeostasis under physiological conditions. To evaluate the physiological relationship among miR-210, ISCU, and TfR expression, we transfected antisense miR-210 oligonucleotide (anti-miR-210), which suppresses the expression of miR-210 (supplemental Fig. S3B ), and control oligonucleotide (anti-NC) into MCF7 cells under a hypoxic condition. We observed the induction of ISCU expression level after the transfection of anti-miR-210 ( Fig. 1F and  supplemental Fig. S2D) ; however, the expression of TfR was not affected (Fig. 3A and  supplemental Fig. 5A ). The knockdown of ISCU has been known to increase the expression of TfR by activating IRP1 activity (Fig. 2C) (26) . From these observations, we assumed that unchanged TfR expression after the transfection of anti-miR-210 was caused by the upregulation of the ISCU expression level by anti-miR-210 (Fig. 3B) , leading to the inhibition of IRP1 activity without the affecting IRP1 expression level. To confirm the change of IRP1 activity by miR-210 expression level in our experiment, we transfected anti-miR-210 or pre-miR-210 into MCF7 cells and analyzed the expression level of ferritin protein, which is the iron storage protein, by immunobloting. Since the 5'UTR of ferritin mRNA contains a single IRE that affects translation initiation, inhibition of IRP1 activity leading the upregulation of ferritin expression (29) . Indeed, the expression level of ferritin was increased in anti-miR-210 transfected cells compared with that in anti-NC transfected cells (Fig. 3C) . On the other hand, overexpression of miR-210 by pre-miR-210 suppressed the expression of ferritin in MCF7 cells, indicating that the activity of IRP1 was modulated by miR-210 through ISCU pathway (supplemental Fig. S5B ). To eliminate the effect of ISCU on TfR expression in this assay system, we established stable ISCU knockdown cell lines using the MCF7 cell. In ISCU knockdown cells, the expression of TfR was higher than that in control cells by activated IRP1 (Fig. 2C and  supplemental Fig. S2E ). We carried out the same experiment as shown in Fig. 3A using ISCU knockdown cell lines and observed that anti-miR-210 increased TfR mRNA and protein level in ISCU knockdown cell lines but not in control cell lines (Fig. 3D) . This result indicated that the expression of TfR was upregulated by not only the downregulation of miR-210 which directly target the TfR but also the activated IRP1 which usually inactivated by ISCU. Furthermore, MCF7 cells were transfected with siRNA against IRP1 (or siNC) and anti-miR-210 (or anti-NC) under hypoxic condition and these cells were analyzed the expression of IRP1 and TfR by immunoblotting. As a result, since the IRP1 is known to stabilize the TfR mRNA, knockdown of IRP1 by siRNA caused to decrease the expression of TfR (Fig. 3E ; compare lane 1 and 2). Importantly, co-transfection of anti-miR-210 and IRP1 siRNA induced the expression of TfR, indicating that miR-210 directly target the TfR in cancer cells ( Fig. 3E; compare lane 2 and 4) . Taken together, these data suggest that miR-210 regulates TfR expression through direct and indirect translational regulatory mechanisms to fine-tune the iron homeostasis (Fig. 3B) . (Fig. 4A  and supplemental Fig. S6A ). We injected 5x10 6 MDA-MB-231-miR-210-sensor cells into nude mice. Prior to the excision of tumors, the mice were administered pimonidazole, a compound that binds irreversibly to hypoxic cells (31) . Serial sections of the tumors were subsequently stained for pimonidazole, HIF-1α, and DsRed. A correlation between HIF-1α-positive cells and DsRed-negative cells, indicative of diminishment of DsRed expression by miR-210, was observed at the hypoxic rim around necrotic regions of the tumor, a location typically associated with chronic hypoxia (Fig. 4B) . We also observed that pimonidazole-positive cells and DsRed-negative cells overlapped. On the other hand, fluorescence of control-miR-210-sensor cells, whose miR-210 binding site was inserted inversely with the miR-210-sensor vector, was not changed in inoculated tumor cells. Furthermore, we also established a cell line which enabled us to trace the expression of miR-210 by its promoter-driven DsRed (Fig. S6B) and obtained similar results with the MDA-MB-231-miR-210-sensor (Fig. S6C) . Together, these observations indicated that the expression of miR-210 was increased in the severely hypoxic region of the tumor. Namely, miR-210 regulates the iron homeostasis in cancer cells under the chronic hypoxic condition in tumors.
The distribution of miR-210-expressing cells is associated with chronic hypoxia
DISCUSSION
Iron is indispensable for the function of many prosthetic groups, whereas excess free iron can oxidize and damage the protein, nucleic acid, and lipid contents of cells. Thus, animals evolved complex mechanisms to control the favorable concentrations of intracellular iron. In this study, we revealed that miR-210 is involved in a novel iron homeostasis mechanism through the association of ISCU and TfR in cancer cells (Fig. 5) . miR-210 downregulates ISCU and the Fe-S cluster in order to mediate the energy metabolic shift from aerobic oxidative phosphorylation to anaerobic glycolysis (32) . Concurrently, reduction of the Fe-S cluster activates IRP1, and, subsequently, the expression of TfR is increased, resulting in the elevated uptake of the iron ion. However, several reports show that the excess iron can be toxic (4) . To reduce the cellular iron concentration, miR-210 directly suppresses the expression of TfR. Thus, miR-210 regulates iron homeostasis and avoids intracellular iron toxicity. Compared to normal cells, cancer cells require a large amount of iron; thus, they generally proliferate at a larger rate than their normal counterparts. Hence, iron chelators exert their anti-proliferative effects on tumors (12) . Moreover, a previous report showed that downregulation of TfR decreased cellular proliferation and altered expression of genes involved in cell cycle control (33) . Thus, as summarized in Fig. 5 , it is postulated that miR-210 has two pathways for the regulation of TfR expression. One is the TfR upregulation pathway via suppression of ISCU (indirect pathway), and the other one is the TfR downregulation pathway by direct binding to TfR mRNA. Reduction of ISCU only increases the binding activity of IRP1, but its level of expression does not change. Thus, the effect of upregulation of TfR by reduced ISCU depends on the amount of IRP1 protein. There are limitations to the upregulation of TfR by the indirect pathway. Then, in the case of a further increase of miR-210, direct suppression of TfR is superior to its upregulation by the indirect pathway. In other words, because the forced expression of miR-210 overwhelms the indirect pathway, the direct pathway is superior to the indirect one. Therefore, exogenous transfection of miR-210 causes TfR suppression (Fig. 2) , thereby reducing cellular proliferation (supplemental Fig. S7) (34,35) . Moreover, we confirmed the overlap of chronic hypoxic regions and miR-210-expressing cells in inoculated cancer cells in vivo. These observations suggest that precise regulation of miR-210 expression level is vital for maintaining the iron homeostasis, leading to the survival and proper cellular proliferation of cancer cells.
HIFs and IRPs are key mediators of cellular iron homeostasis and oxygen, respectively. Since iron and oxygen are often intimately connected in their metabolism, it is not surprising that their levels are coordinately regulated in cells. Such cross-talk is achieved in part by cellular regulatory factors that sense and by guest on January 9, 2018 http://www.jbc.org/ Downloaded from respond to both iron and oxygen, and it is reinforced by the overlap in the gene targets regulated by each pathway. For instance, binding of IRPs protects TfR mRNA from degradation, and HIF-1α activates TfR gene transcription (36, 37) . In addition, in the present study, we identified that hypoxia-inducible miR-210 was a key component of this pathway. As noted above, we have clearly shown that iron homeostasis is micromanaged by miRNAs. Therefore, miRNAs could be essential for maintaining other metal homeostasis in mammalian, for example, copper, zinc and cadmium. In agreement with our observations, the current view on the molecular understanding of miRNA-guided regulation of plant heavy metal adaption was reported (38, 39) . Dysregulation of metal homeostasis-related miRNAs may contribute to various diseases including cancers, nephropathy and autoimmune disease. Further analyses are required how these miRNAs can be affected by genetic and epigenetic mechanisms in the physiological and pathological microenvironments. Lower panel show schematic representation of the regulation of miR-210 target gene after treatment with anti-miR-210 in ISCU_KD cells. Since ISCU was stably suppressed by shRNA in this cells, the activity of IRP1 was increased (grey box). Therefore, in this experiment, TfR was upregulated by not only the downregulation of miR-210 which directly target the TfR but also the activation by IRP1. (E) MCF7 cells were transfected with anti-miR-210 or anti-NC and siIRP1 or siNC and exposed to 1% O 2 for 48 h. Expression of IRP1 (upper) and TfR (middle) was detected by immunoblotting. Actin was used as a loading control. Lower panel show schematic representation of the regulation of miR-210 target gene after treatment with anti-miR-210 and siIRP1. Since the expression of IRP1 was suppressed by siRNA, there is no influence on the TfR expression by "indirect pathway" (grey box). On the other hand, the expression of miR-210 was downregulated by anti-miR-210. As a result, TfR was upregulated in this experiment. by guest on January 9, 2018 
